News

MustGrow Biologics Corp. (MGROF) – Extending an Agreement

Health
0 min read

Friday, August 19, 2022

MustGrow Biologics Corp. (MGROF)
Extending an Agreement

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Sumitomo Extension. MustGrow announced Wednesday that the Company has extended the option with Sumitomo for exclusive testing with MustGrow’s technology on potatoes and bananas in North, Central, and South America. The Company did not disclose the length of the extension.

Positive Results. During Sumitomo’s use of MustGrow’s mustard-based products for preplant soil fumigation, bioherbicide, and postharvest and food preservation, Sumitomo’s efforts have shown positive levels of efficacy in comparison to certain synthetic chemical standards. With the extension, Sumitomo will to continue to drive all field development, along with regulatory and market assessment work for commercialization. We believe this to be a testament to the safeness and efficacy of MustGrow’s technology and believe this to be a step forward towards seeing top-line revenue….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Comments

0
No comments yet...
Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.